Author: admin

ViiV Healthcare to triple supply of long-acting HIV prevention drug by 2026

USA – ViiV Healthcare has announced plans to increase its supply of long-acting cabotegravir (CAB LA) for HIV pre-exposure prophylaxis (PrEP), aiming to triple its annual production to at least two million doses by 2025/26. This bold move targets low- and middle-income countries (L&MICs) to help populations facing high HIV infection rates and limited access […]

GE HealthCare takes leading role in new consortium to broaden access to theranostics across Europe

USA – GE HealthCare has announced its leading role in Thera4Care, a €25.3 million (US$ 27.8 million) project aimed at revolutionizing cancer treatment through the use of theranostics. This innovative approach combines imaging diagnostics with targeted therapeutics, allowing for personalized cancer care by identifying tumor receptors and delivering radioactive drugs directly to the cancer cells. […]

Issue 4

Issue 3

Issue 2